Amblyopia is a neurodevelopmental disorder of vision typically manifesting as reduced visual acuity in one eye and abnormal binocular function. Current treatments for amblyopia are usually administered in childhood and include occlusion or “patching”.
This trial involves treatment using a prototype device (the Amblyoptica device) The device is worn in a manner like spectacles. The purpose of this trial is to assess if there is any improvement in visual acuity and binocular function in people with amblyopia (Lazy Eye).
Your support will help us recruit the best researchers to develop better treatments, purchase the latest equipment, advance clinical trials of new treatments, improve eye health education, and support talented students to become tomorrow’s leaders in eye research.
For the health and safety of our patients, staff and visitors, we ask you do not enter the QEI South Brisbane or QEI Clayfield facilities if you:
Please note that all visitors at this time will undergo contactless temperature checking. Our staff will also require the full names and contact details of all visitors to the building.
Thank you for your cooperation at this time, please don't hesitate to contact us on 07 3239 5000 if you have any concerns.